2021
DOI: 10.2174/1871526520666201019122205
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Hepatitis C Cirrhotic Patients With Directly Acting Antivirals: A Multicenter Study

Abstract: Background &Aims: With the introduction of sofosbuvir based regimens, there have been achieved high cure rates and decreased duration. Several studies showed variances in SVR rates between different genotypes, with lower rates of SVR among cirrhotic patients . The aim of our study was to assess the safety and effectiveness of sofosbuvir-based antiviral regimens for the treatment of HCV-infected Egyptian cirrhotic patients. Methods: This was a retrospective observational comparative study. Nine hundred … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
14
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(14 citation statements)
references
References 0 publications
0
14
0
Order By: Relevance
“…High-risk children are already under focus and screening for viral According to WHO, there were approximately 71 million people living with chronic HCV in 2015 with the highest prevalence in the eastern Mediterranean region (23%), followed by the European region (15%), and the African region (1%). [1][2][3][4][5][6][7][8][9][10][11] As a result, in some countries, the true prevalence of HCV in adolescents and children may be underestimated. According to data from the United States, HCV prevalence is rising in adolescents, who has been connected to the opioid epidemic and rising HCV infection rates among women of reproductive age.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…High-risk children are already under focus and screening for viral According to WHO, there were approximately 71 million people living with chronic HCV in 2015 with the highest prevalence in the eastern Mediterranean region (23%), followed by the European region (15%), and the African region (1%). [1][2][3][4][5][6][7][8][9][10][11] As a result, in some countries, the true prevalence of HCV in adolescents and children may be underestimated. According to data from the United States, HCV prevalence is rising in adolescents, who has been connected to the opioid epidemic and rising HCV infection rates among women of reproductive age.…”
Section: Discussionmentioning
confidence: 99%
“…HCV infection raises the risk of morbidity and mortality, and it is the major cause of end‐stage liver disease, cirrhosis and liver cancer in people all over the world 18–23 . Despite the fact that HCV infection seldom causes morbidity in children, the majority of HCV‐infected children develop chronic HCV, putting them at risk for life‐threatening liver disease 9–26 …”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations